News and calendar

Earlier this year the UZ Leuven expert teams that joined the European Rare Disease Reference Networks (ERNs) in 2017 participated in an evaluation of their accreditation as centres of expertise. Following their evaluation, 18 teams can renew their accreditation for five years.

Good new for patients with Crohn's disease: the new, promising drug risankizumab is since recently being reimbursed. Another two drugs will come on the market soon: one for Crohn's disease and another for colitis ulcerosa, that other chronic inflammatory bowel disease.

Ground-breaking international research that UZ Leuven participated in, provides important insights about the complex relationship between hormones and male health.

On Saturday 23rd September 2023 the pneumology department of UZ Leuven is organising the seminary “From end-stage lung disease to lung transplantation”. This seminary will be organised on the occasion of the emeritus of prof. dr. Geert Verleden later this year.